CTRI/2022/02/040442
Not yet recruiting
Phase 3
Comparative study between weekly dose of 50mg Mifepristone and daily dose of 25 mg Mifepristone in medical management of UTERINE FIBROID
Dr Subhasri S0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Dr Subhasri S
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Women of age group 30\-45
- •Women with symptomatic fibroid
- •Fibroid size 3\-5cm
- •Without endometrial hyperplasia
Exclusion Criteria
- •Uterine size more than 12weeks
- •Associated cervical or tubal lesions
- •Fibroid with severe anemia
- •Hepatic and renal dysfunction
- •Endometrial hyperplasia
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A comparative pharmacokinetic study of oral mifepristone and vaginal misoprostol in pregnant womePregnancyPregnancy and ChildbirthISRCTN35300716World Health Organization (WHO) (Switzerland)60
Recruiting
Phase 2
To compare Oral Mifepristone with Foley catheter for softening of cervix in women planned for delivery at or after 39 weeks of pregnancyCTRI/2021/07/034943JIPMER INTRAMURA
Completed
Not Applicable
Study comparing two methods of abortion in second trimester using misoprostol or ethacridine lactate after priming with mifepristoneHealth Condition 1: null- SECOND TRIMESTER ABORTIONSCTRI/2018/01/011157Project in the Department of Obstetrics and Gynecology120
Active, not recruiting
Not Applicable
Comparison between two different dosages of remifentanil administered by a patient controlled tecnique (PCSA) for diagnostic and andoscopich procedures. - NDEUCTR2009-010383-42-ITOSPEDALE S. RAFFAELE
Completed
Not Applicable
Misoprostol for induction of laborCTRI/2012/07/002785Sikkim Manipal Institute of Medical Sciences250